Target intelligence / Profile preview

RNA, U1 small nuclear 44, pseudogene (RNU1-44P)

Target
RNU1-44P
Molecular classification
Pseudogene, Other
01

Overview

RNU1-44P is annotated as a pseudogene of the U1 small nuclear RNA (snRNA) gene family, specifically the 44th pseudogene member. U1 snRNA is a core component of the spliceosomal machinery, recognizing the 5′ splice site during pre-mRNA splicing and involved in a process called telescripting, safeguarding nascent transcripts from premature termination. However, RNU1-44P itself does not encode a functional snRNA and lacks evidence of biological activity, drug interaction, disease association, or recognized therapeutic targeting. U1 snRNA family members (such as RNU1-1, RNU1-2, RNU1-4) are well-studied for their role in splicing and gene regulation, but pseudogene variants (such as RNU1-44P) are generally nonfunctional and do not produce mature or functional RNA molecules. There are no known drugs, mechanisms of action, or biomarker roles for RNU1-44P. Pseudogenes are typically genomic DNA sequences similar to functional genes but rendered non-functional due to mutations or deletions. They may have regulatory roles in rare cases, but there is no evidence for RNU1-44P in the literature or curated databases. RNU1-44P does not fit into canonical molecular families such as receptor, enzyme, channel, or transcription factor. This entry is a pseudogene, not a functional RNA or classical therapeutic target. If you intend to study therapeutically relevant or functional molecules in the U1 snRNA family, refer to canonical snRNA genes (e.g., RNU1-1, RNU1-2, RNU1-4). No actionable disease or drug association reported. No established biological or clinical relevance for patient selection, monitoring, or safety. In summary: RNU1-44P is a pseudogene related to the U1 small nuclear RNA gene family, lacking functional RNA production, protein-coding potential, and relevance as a therapeutic target. No alternative names, drug interactions, disease associations, mechanisms of action, biomarker roles, or safety concerns are described in peer-reviewed databases or expert sources.

Other names
RNU1-44P

Beyond the preview

Go deeper on RNA, U1 small nuclear 44, pseudogene (RNU1-44P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 44, pseudogene (RNU1-44P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call